GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Banque Cantonale Vaudoise

Banque Cantonale Vaudoise grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 70.3% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 27,522 shares of the company's stock after buying an additional 11,360 shares during the period. Banque Cantonale Vaudoise's holdings in GE HealthCare Technologies were worth $2,583,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Quent Capital LLC raised its position in GE HealthCare Technologies by 18.4% during the 3rd quarter. Quent Capital LLC now owns 766 shares of the company's stock worth $72,000 after buying an additional 119 shares during the last quarter. Greenleaf Trust raised its stake in GE HealthCare Technologies by 1.7% in the 3rd quarter. Greenleaf Trust now owns 7,619 shares of the company's stock valued at $715,000 after purchasing an additional 124 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in GE HealthCare Technologies by 8.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,590 shares of the company's stock valued at $135,000 after purchasing an additional 127 shares during the last quarter. Quarry LP grew its holdings in GE HealthCare Technologies by 28.3% in the 2nd quarter. Quarry LP now owns 594 shares of the company's stock valued at $46,000 after buying an additional 131 shares in the last quarter. Finally, Harbour Investments Inc. grew its holdings in GE HealthCare Technologies by 4.3% in the 3rd quarter. Harbour Investments Inc. now owns 3,164 shares of the company's stock valued at $297,000 after buying an additional 131 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on GEHC shares. Wells Fargo & Company increased their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. Stifel Nicolaus raised their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a "buy" rating in a research note on Monday, September 30th. Redburn Atlantic upgraded GE HealthCare Technologies to a "strong-buy" rating in a research note on Thursday, August 1st. UBS Group downgraded GE HealthCare Technologies from a "neutral" rating to a "sell" rating and decreased their price target for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Finally, JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a report on Monday, September 9th. They set a "neutral" rating and a $90.00 price objective for the company. One investment analyst has rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $94.36.

Insider Buying and Selling

In related news, CEO Roland Rott sold 3,577 shares of the firm's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares of the company's stock, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.27% of the company's stock.

GE HealthCare Technologies Trading Up 2.9 %

Shares of NASDAQ:GEHC traded up $2.38 during midday trading on Wednesday, reaching $84.90. The company's stock had a trading volume of 6,101,936 shares, compared to its average volume of 3,058,728. The business has a 50 day moving average price of $88.54 and a 200 day moving average price of $83.58. GE HealthCare Technologies Inc. has a 1 year low of $66.39 and a 1 year high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm has a market cap of $38.79 billion, a price-to-earnings ratio of 23.32, a price-to-earnings-growth ratio of 2.93 and a beta of 1.24.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter in the prior year, the business earned $0.99 earnings per share. The company's revenue was up .9% compared to the same quarter last year. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. The ex-dividend date of this dividend was Friday, October 18th. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.30%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.